Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis (original) (raw)

Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies

Agneta Wikman

Acta Obstetricia et Gynecologica Scandinavica, 2013

View PDFchevron_right

One single dose of 200 μg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy

Joke Koelewijn

Transfusion, 2008

View PDFchevron_right

RH D Foeto-Maternal Alloimmunization Prophylaxis with Anti-D Immunoglobulins Reviewed in the Era of Foetalrhdgenotyping

Christiane Gerard

Acta Clinica Belgica, 2009

View PDFchevron_right

A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant

Catherine Beverley

BJOG: An International Journal of Obstetrics & Gynaecology, 2004

View PDFchevron_right

Targeted Routine Antenatal Anti-D Prophylaxis in the Prevention of RhD Immunisation - Outcome of a New Antenatal Screening and Prevention Program

Agneta Wikman

PLoS ONE, 2013

View PDFchevron_right

The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh (D) alloimmunisation

Angelo Dalessandro

2010

View PDFchevron_right

Anti-D Prophylaxis Reviewed in the Erea of Foetal RHD Genotyping

Jean-marc Minon

Journal of Blood Disorders & Transfusion, 2015

View PDFchevron_right

Rh isoimmunization in Sub-Saharan Africa indicates need for universal access to anti-RhD immunoglobulin and effective management of D-negative pregnancies

PROFESSOR OSARO ERHABOR

International Journal of Women's Health, 2010

View PDFchevron_right

Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn

John Napier

BJOG: An International Journal of Obstetrics and Gynaecology, 1988

View PDFchevron_right

A Multicenter, Randomized, Open-Label Trial Comparing the Efficacy and Safety of Monoclonal Anti-Rh (D) Immunoglobulin with Polyclonal Anti-Rh (D) Immunoglobulin for the Prevention of Maternal Rh-Isoimmunization

Rahul Mayekar

The Journal of Obstetrics and Gynecology of India, 2019

View PDFchevron_right

Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy*

Joke Koelewijn

BJOG: An International Journal of Obstetrics & Gynaecology, 2009

View PDFchevron_right

A management programme for Rh alloimmunization during pregnancy

Sergey Lindeberg

Early Human Development, 1987

View PDFchevron_right

RhD immunisation in pregnancy

Hans Erik Heier

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2016

View PDFchevron_right

Feto-maternal outcomes of women with Rhesus iso-immunization in a Nigerian tertiary health care institution

charlotte oguejiofor

Journal of Pregnancy and Neonatal Medicine, 2017

View PDFchevron_right

Consequences for fetus and neonate of maternal red cell allo-immunisation

Cyril Clarke SS

Archives of Disease in Childhood - Fetal and Neonatal Edition, 1998

View PDFchevron_right

Non RhD isoimmunization causing severe hemolytic disease of fetus and newborn in Rh positive pregnancies: report of 2 cases with review of literature

Sangeeta Pahuja

International Journal of Contemporary Pediatrics, 2020

View PDFchevron_right

Post-marketing safety evaluation of recombinant anti-Rho (D) immunoglobulin for the prevention of maternal Rh-isoimmunization: A prospective, multi-centre, phase IV study

Pratik Shah, Innovative Publication

Indian Journal of Obstetrics and Gynecology Research, 2023

View PDFchevron_right

The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative

Myfanwy Jones

BJOG: An International Journal of Obstetrics & Gynaecology, 2004

View PDFchevron_right

Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation‐wide population study prior to routine antenatal anti‐D prophylaxis

Hulda Hjartardottir

Transfusion, 2019

View PDFchevron_right

Report of the first nationally implemented clinical routine screening for fetal RHD in D− pregnant women to ascertain the requirement for antenatal RhD prophylaxis

Frederik Skytte Clausen

Transfusion, 2011

View PDFchevron_right

Impact of Immunization Prophylaxis on the Course of Pregnancy in Rh-Negative Women

Turab Janbakhishov

Ukraïnsʹkij žurnal medicini, bìologìï ta sportu

View PDFchevron_right

Effect of Screening for Red Cell Antibodies, Other Than Anti-D, to Detect Hemolytic Disease of the Fetus and Newborn: A Population Study in The Netherlands

Joke Koelewijn

Obstetrical & Gynecological Survey, 2008

View PDFchevron_right

Rh Isoimmunization - Update

HOSSAM FADEL

Journal of the Islamic Medical Association of North America, 1987

View PDFchevron_right

Rh (D) phenotype among pregnant women in Sokoto, North Western Nigeria. Implications on haemolytic disease of the new-born and haemolytic transfusion reaction

swati Singh

View PDFchevron_right

Should anti-Rh immunoglobulin be given to D variant women?

Marcela Contreras

British Journal of Haematology, 1989

View PDFchevron_right

Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping

Barbora Dybvik

Fetal Diagnosis and Therapy

View PDFchevron_right

Polyclonal Anti-D Antibodies Significantly Reduce the Rate of Miscarriages in Rh(D) positive Women with Recurrent Pregnancy loss

Fortune Journals

View PDFchevron_right

Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities

Morten Hedegaard

Transfusion, 2009

View PDFchevron_right

D antibodies in pregnant women in multiethnic Suriname: the observational RheSuN study

Wilco Zijlmans

Transfusion, 2017

View PDFchevron_right

Monitoring and treatment of anti-D in pregnancy

Pavel Calda, D. Bettelheim

Vox Sanguinis, 2010

View PDFchevron_right

Antenatal bleeding: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Isaac Babarinsa

Vaccine, 2017

View PDFchevron_right

Management of Rhesus Isoimmunized Pregnant Woman in Low Resource Setting: A Case Report

alhassan Isah

2021

View PDFchevron_right